NCERT grounding
NCERT Class 12 Biology, Chapter 10 (Biotechnology and its Applications), Section 10.2.3 is the only anchor a NEET aspirant needs for this subtopic. Its opening line frames the entire problem of molecular diagnosis — that conventional serum and urine analysis cannot see a pathogen until it has already multiplied to symptom-producing levels. Three tools, the textbook says, restore early detection: recombinant DNA technology, the Polymerase Chain Reaction (PCR) and Enzyme Linked Immuno-Sorbent Assay (ELISA). A fourth tool — a radioactively-labelled single-stranded probe used with autoradiography — is described in the same section for catching mutant genes inside cell clones.
"For effective treatment of a disease, early diagnosis and understanding its pathophysiology is very important. Using conventional methods of diagnosis (serum and urine analysis, etc.) early detection is not possible."
NCERT Class 12 Biology · Section 10.2.3
Almost every NEET question on this subtopic is a paraphrase of one of four NCERT sentences: PCR detects very low amounts of nucleic acid by amplification (used for HIV in suspected AIDS patients and mutated genes in suspected cancer patients); a radioactive probe hybridises with complementary DNA and the mutant clone is identified by its absence on the photographic film; ELISA rests on antigen-antibody interaction; and infection is detected either by pathogen antigens or by antibodies synthesised against the pathogen. Memorise those four sentences and the NEET trap surface area collapses to almost nothing.
Three techniques, three molecular levels
The cleanest way to hold this subtopic in your head is to read it as a layered diagnostic stack. PCR sits at the nucleic-acid level: it copies pathogen DNA (or a mutated host gene) until even a handful of starting molecules become visible. ELISA sits at the protein level: it reports the presence of pathogen antigens or of the patient's own antibodies. The radiolabelled probe operates at the gene-sequence level inside a clone of cells: it tells you which colony carries the normal or the mutated copy of a gene.
Techniques in NCERT 10.2.3
Recombinant DNA technology, PCR and ELISA are the techniques NCERT lists as serving the purpose of early diagnosis. Serum and urine analysis (the conventional set) is explicitly excluded from this list — the basis of the 2023 PYQ.
Because all three are deployed for the same clinical problem — catching disease before the patient feels sick — students routinely mix up which technique reads which molecule. The matching is fixed: PCR uses primers and DNA polymerase to amplify nucleic acid through temperature cycles; ELISA uses an enzyme-conjugated antibody to convert a substrate into a coloured product; the DNA probe uses radioactivity plus complementary base pairing. Each technique exists because the other two cannot do its job. PCR cannot detect antibodies. ELISA cannot amplify a sub-detection-level pathogen. The probe cannot survey a blood sample in vivo.
PCR
DNA / RNA
Nucleic-acid level
- Amplifies pathogen genome or host mutation
- HIV in suspected AIDS patients
- Mutated genes in suspected cancer patients
- Detects before antibody response
ELISA
Ag / Ab
Protein level
- Detects pathogen antigens in patient
- Detects antibodies made by patient
- Antigen-antibody interaction principle
- Widely used for AIDS diagnosis
PCR — amplifying pathogen DNA
The Polymerase Chain Reaction copies a target DNA segment exponentially in a test tube. The reaction needs five things: the template DNA (which may be just a few molecules of pathogen genome extracted from a patient sample), two short single-stranded oligonucleotide primers that flank the target, the four deoxynucleotide triphosphates, a thermostable DNA polymerase such as Taq polymerase isolated from Thermus aquaticus, and a magnesium-containing buffer. The PCR tube is then cycled through three temperatures in a thermocycler.
Each cycle has the same three steps. Denaturation at about 94 °C melts the double helix into two single strands by breaking the hydrogen bonds between bases. Annealing at about 50 °C lets each primer find its complementary stretch on the single-stranded template and base-pair there. Extension at about 72 °C is the working temperature of Taq polymerase: it adds nucleotides in the 5′→3′ direction onto the 3′ end of each primer, synthesising a new strand complementary to the template. At the end of one cycle the original DNA has been doubled. Repeated cycles double the doubling; after roughly 30 cycles a single starting molecule has produced over a billion identical copies, more than enough to visualise as a sharp band on an agarose gel.
One PCR cycle — three temperatures, three jobs
-
Step 1
Denaturation
~94 °C. Heat splits the double helix into two single-stranded templates by breaking hydrogen bonds.
High temperature -
Step 2
Annealing
~50 °C. Two short primers base-pair with their complementary sequences flanking the target on each single strand.
Primer binding -
Step 3
Extension
~72 °C. Thermostable Taq DNA polymerase adds dNTPs to the 3′ end of each primer, copying the template. Cycle repeats.
Taq polymerase
The clinical payoff is the answer to the NCERT question "Can you explain how PCR can detect very low amounts of DNA?" Because each cycle approximately doubles the target, even a sub-detection-level load of pathogen nucleic acid is brought up to a readily visible quantity. NCERT names two flagship uses: HIV detection in suspected AIDS patients (PCR catches viral RNA, reverse-transcribed to cDNA, during the antibody-negative window) and detection of mutations in genes in suspected cancer patients. The textbook explicitly extends this to "many other genetic disorders" — sickle-cell anaemia, β-thalassaemia, cystic fibrosis and others tested by mutation-specific PCR.
Figure 1. One thermal cycle of PCR. The double helix is melted at 94 °C, two flanking primers anneal at about 50 °C, and a thermostable polymerase extends new strands at 72 °C. Each cycle doubles the target — sub-detection-level pathogen DNA becomes a visible band after roughly thirty cycles.
ELISA — antigen-antibody readout
ELISA — Enzyme Linked Immuno-Sorbent Assay — is the workhorse of clinical immunodiagnostics. NCERT condenses its principle into a single sentence: it is based on antigen-antibody interaction. The assay is performed on a polystyrene microtitre plate whose wells are coated with a "capture" molecule. Patient serum, urine or plasma is then added and any matching analyte binds. A second, enzyme-linked antibody is washed in, and finally a colourless substrate is added. If the analyte was present, the enzyme — typically horseradish peroxidase or alkaline phosphatase — converts the substrate into a coloured product whose intensity is read in a plate reader.
The textbook then makes the two clinically critical points. Infection by a pathogen can be detected by the presence of antigens derived from the pathogen — proteins, glycoproteins — present in the patient sample. Alternatively, infection can be detected by the antibodies synthesised against the pathogen by the patient's own immune system. Both routes are antigen-antibody interactions, but they look in opposite directions: one looks for a foreign protein in the host, the other looks for the host's response to it. ELISA is therefore the dominant screening test for diseases like AIDS, where anti-HIV antibodies appear in serum weeks after infection.
NCERT cue: two ways an infection can be detected by ELISA — pathogen antigen or patient antibody. NEET item-writers shuffle between the two; the answer is always "either."
Detect antigen
Target: pathogen-derived proteins or glycoproteins in the patient sample.
Reporter: enzyme-linked anti-pathogen antibody → coloured substrate.
NCERT 10.2.3Detect antibody
Target: antibodies the patient has synthesised against the pathogen.
Reporter: enzyme-linked anti-human-IgG → coloured substrate.
AIDS screeningPrinciple
Antigen-antibody interaction — the single phrase NEET expects.
Readout: colour development by a linked enzyme converting its substrate.
DefinitionFigure 2. ELISA in four steps. A capture antibody on the well surface binds pathogen antigen from the patient sample; an enzyme-linked detection antibody is added; the bound enzyme converts a colourless substrate into a coloured product whose intensity, read by a plate reader, is proportional to the antigen present. The antibody-detection format mirrors this layout but with antigen on the well and patient antibody as the captured molecule.
Radiolabelled DNA probe & autoradiography
Sandwiched between PCR and ELISA in NCERT 10.2.3 is a short paragraph on the radioactive probe — a tool used to identify the cells in a clone that carry a particular mutated gene. A single-stranded DNA or RNA tagged with a radioactive molecule (the probe) is allowed to hybridise to its complementary DNA in a clone of cells, and the result is read by autoradiography. The probe is designed against the normal sequence. Wherever the normal sequence is present, the probe base-pairs with it and deposits a radioactive signal; on developed photographic film that location shows a dark spot.
The diagnostic logic is inverted from PCR and ELISA: presence of signal means the normal gene; absence of signal means the mutant. NCERT puts this as plainly as it can: "The clone having the mutated gene will hence not appear on the photographic film, because the probe will not have complementarity with the mutated gene." NEET 2021 Code-P3 Question 150 (reproduced below) tests exactly this sentence — and the most popular wrong choice is the option that says the mutant does appear, exactly because most students remember that probes detect things and forget that here the detector is reporting absence.
"Not appearing" is the positive result for the mutant.
The probe is complementary to the normal sequence. Normal clones bind the probe and expose the film — they show up as dark spots. Mutant clones lack complementarity, the probe washes away, and the film stays blank at that spot. The blank spot identifies the mutant.
Rule: probe sees normal; the empty spot on the film is the cancer-mutant clone.
Worked examples
A clinician needs to confirm an HIV infection in a patient whose serological tests are still ambiguous because antibodies have not yet appeared in detectable quantity. Which technique should be ordered, and why?
PCR. ELISA depends on antigen-antibody interaction, so it can only flag the infection once either viral antigen has crossed the assay threshold or the patient has mounted a detectable antibody response. PCR is independent of the immune response — it amplifies the viral nucleic acid itself. NCERT 10.2.3 specifies that PCR is "routinely used to detect HIV in suspected AIDS patients" and explains the underlying mechanism: amplification of nucleic acid means even very low concentrations of virus can be detected before symptoms (or antibodies) appear.
In a PCR run aimed at amplifying a 1-kb fragment of bacterial DNA, three temperature steps are used per cycle. Identify the temperature, the enzyme/molecule active at each step, and what would happen if a heat-labile DNA polymerase were used instead of Taq.
94 °C — denaturation; only hydrogen-bond breakage, no enzyme is acting. 50 °C — annealing; the two short primers find their complementary sequences flanking the target. 72 °C — extension; Taq DNA polymerase adds dNTPs to the 3′ end of each primer in the 5′→3′ direction. Substituting a heat-labile polymerase would mean the enzyme is permanently denatured during the first 94 °C step, and fresh enzyme would have to be added every cycle — making the reaction unworkable. The thermostability of Taq, isolated from Thermus aquaticus, is what makes PCR practical.
An ELISA plate is being run to screen donated blood for hepatitis B. Wells coated with anti-HBsAg capture antibody develop a strong yellow colour after enzyme-substrate addition in some wells and remain colourless in others. Interpret the result.
Colour development means the HBsAg antigen was present in that sample — the capture antibody bound it, the enzyme-linked detection antibody bound the captured antigen, and the enzyme converted the colourless substrate into a coloured product. Colourless wells indicate the absence of HBsAg in those samples. The signal is a direct readout of antigen-antibody interaction (the NCERT principle of ELISA) and the intensity is roughly proportional to antigen concentration.